Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Ronghe Medical | 2025 | Series B | $14.1M | Hangzhou |
| Dexmal | 2025 | Series A | Undisclosed | Beijing |
| TandemAI | 2025 | Series A | $22.0M | Shanghai |
| Vybio | 2025 | Series B | $14.1M | Hangzhou |
| Brise Pharma | 2025 | Series A | $28.1M | Shanghai |
| Cornerstone Robotics | 2025 | Series Unknown | $200.0M | Hong Kong |
| WeRide | 2025 | Post Ipo Equity | $308.0M | Guangzhou Shi |
| Changsen Pharmaceutical | 2025 | Series B | $283.9M | Shanghai |
| Theraheart | 2025 | Series A | $20.6M | Irvine |
| Future Intelligence | 2025 | Series A | $14.0M | Hefei |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Ronghe Medical | Series B | $14.1M | Hangzhou, China |
| 77 | Dexmal | Series A | Undisclosed | Beijing, China |
| 78 | TandemAI | Series A | $22.0M | Shanghai, China |
| 79 | Vybio | Series B | $14.1M | Hangzhou, China |
| 80 | Brise Pharma | Series A | $28.1M | Shanghai, China |
| 81 | Cornerstone Robotics | Series Unknown | $200.0M | Hong Kong, Hong Kong |
| 82 | WeRide | Post Ipo Equity | $308.0M | Guangzhou Shi, China |
| 83 | Changsen Pharmaceutical | Series B | $283.9M | Shanghai, China |
| 84 | Theraheart | Series A | $20.6M | Irvine, United States |
| 85 | Future Intelligence | Series A | $14.0M | Hefei, China |
Ronghe Medical is a medical device manufacturer specializing in the design, R&D, production, and sales of high-end medical device systems.
Dexmal is a start-up focusing on embodied intelligence technology.
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
Vybio is a high-tech enterprise focusing on innovative drug research and development.
Brise Pharma operates in the scientific research and technical service industry.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
WeRide is an autonomous driving company that develops and operates self-driving technologies for transportation services.
Changsen Pharmaceutical is a high-tech enterprise specializing in the research and development of oncology drugs.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
Future Intelligence is a technology startup focused on making human-computer interaction more feasible.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Hugemed manufactures of medical devices and provides solutions in the field of endoscopy.
Thorough Future helps in integrating cutting-edge technology into medical care, delivering more accurate and efficient diagnostic services.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
VINNO Technology is an international company that provides the fastest medical solutions in every situation.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Agloe Medical is a company offering research, development, and sales of Class II and Class III medical devices and electronic components.
Fasikl is a neuro-AI company that creates interfaces for the nervous system.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.
GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.
Mech-Mind is a global leading provider of industrial 3D sensors and AI-powered software for intelligent robots.
Sany Hydrogen Energy focuses on R&D, manufacturing, and solutions for water electrolysis hydrogen production.
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Medical, Biotechnology, Health Care, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 31 different industry categories.
Among tracked funding rounds, WeRide received $308.0M in a Post Ipo Equity round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include Ronghe Medical, Dexmal, TandemAI, Vybio, Brise Pharma. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors